Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Corticosteroid plus β2-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis.

Wang G, Zhang X, Zhang HP, Wang L, Kang Y, Barnes PJ, Wang G.

Respir Res. 2017 Dec 6;18(1):203. doi: 10.1186/s12931-017-0687-6. Review.

2.

Description of the protocol for the PRACTICAL study: a randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma.

Fingleton J, Hardy J, Baggott C, Pilcher J, Corin A, Hancox RJ, Harwood M, Holliday M, Reddel HK, Shirtcliffe P, Snively S, Weatherall M, Beasley R.

BMJ Open Respir Res. 2017 Jul 29;4(1):e000217. doi: 10.1136/bmjresp-2017-000217. eCollection 2017.

3.

The SYGMA programme of phase 3 trials to evaluate the efficacy and safety of budesonide/formoterol given 'as needed' in mild asthma: study protocols for two randomised controlled trials.

O'Byrne PM, FitzGerald JM, Zhong N, Bateman E, Barnes PJ, Keen C, Almqvist G, Pemberton K, Jorup C, Ivanov S, Reddel HK.

Trials. 2017 Jan 10;18(1):12. doi: 10.1186/s13063-016-1731-4.

4.

Beta-Adrenergic Agonists.

Barisione G, Baroffio M, Crimi E, Brusasco V.

Pharmaceuticals (Basel). 2010 Mar 30;3(4):1016-1044. Review.

5.

2016 Respiratory Effectiveness Group Annual Summit Report-impact & influence of real-world respiratory evidence.

Chisholm A, Eid N, Alcázar-Navarrete B, Barot A, Christoff G, Price DB.

J Thorac Dis. 2016 Jul;8(Suppl 5):S435-44. doi: 10.21037/jtd.2016.07.16. No abstract available.

6.

Management of asthma in Benin: the challenge of loss to follow-up.

Ade G, Gninafon M, Tawo L, Aït-Khaled N, Enarson DA, Chiang CY.

Public Health Action. 2013 Mar 21;3(1):76-80. doi: 10.5588/pha.12.0080. Epub 2013 Feb 28.

7.

Bronchial asthma--Issues for the developing world.

Behera D, Sehgal IS.

Indian J Med Res. 2015 Apr;141(4):380-2. doi: 10.4103/0971-5916.159237. No abstract available.

8.

Stepping down inhaled corticosteroids from scheduled to as needed in stable asthma: Systematic review and meta-analysis.

Gionfriddo MR, Hagan JB, Hagan CR, Volcheck GW, Castaneda-Guarderas A, Rank MA.

Allergy Asthma Proc. 2015 Jul-Aug;36(4):262-7. doi: 10.2500/aap.2015.36.3850. Review.

9.

Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.

Agarwal R, Dhooria S, Aggarwal AN, Maturu VN, Sehgal IS, Muthu V, Prasad KT, Yenge LB, Singh N, Behera D, Jindal SK, Gupta D, Balamugesh T, Bhalla A, Chaudhry D, Chhabra SK, Chokhani R, Chopra V, Dadhwal DS, D'Souza G, Garg M, Gaur SN, Gopal B, Ghoshal AG, Guleria R, Gupta KB, Haldar I, Jain S, Jain NK, Jain VK, Janmeja AK, Kant S, Kashyap S, Khilnani GC, Kishan J, Kumar R, Koul PA, Mahashur A, Mandal AK, Malhotra S, Mohammed S, Mohapatra PR, Patel D, Prasad R, Ray P, Samaria JK, Singh PS, Sawhney H, Shafiq N, Sharma N, Sidhu UP, Singla R, Suri JC, Talwar D, Varma S.

Lung India. 2015 Apr;32(Suppl 1):S3-S42. doi: 10.4103/0970-2113.154517. No abstract available.

10.

Emerging issues in pediatric asthma: gaps in EPR-3 guidelines for infants and children.

Jackson DJ.

Curr Allergy Asthma Rep. 2014 Dec;14(12):477. doi: 10.1007/s11882-014-0477-x. Review.

11.

Comparative effectiveness of long term drug treatment strategies to prevent asthma exacerbations: network meta-analysis.

Loymans RJ, Gemperli A, Cohen J, Rubinstein SM, Sterk PJ, Reddel HK, Jüni P, ter Riet G.

BMJ. 2014 May 13;348:g3009. doi: 10.1136/bmj.g3009. Review.

12.

Section 3. A discussion of flexible dosing and patient-centered therapy: highlights of the asthma summit 2009: beyond the guidelines.

Canonica GW, Brightling C.

World Allergy Organ J. 2010 Feb 15;3(2):31-7. doi: 10.1097/WOX.0b013e3181d27cd8.

13.

Lost to follow-up in asthmatics does not mean treatment failure: causes and clinical outcomes of non-adherence to outpatient treatment in adult asthma.

Kang MG, Kim JY, Jung JW, Song WJ, Cho SH, Min KU, Kang HR.

Allergy Asthma Immunol Res. 2013 Nov;5(6):357-64. doi: 10.4168/aair.2013.5.6.357. Epub 2013 Sep 27.

14.

Symptom-based controller therapy: a new paradigm for asthma management.

Divekar R, Ameredes BT, Calhoun WJ.

Curr Allergy Asthma Rep. 2013 Oct;13(5):427-33. doi: 10.1007/s11882-013-0375-7. Review.

15.

'The blue one takes a battering' why do young adults with asthma overuse bronchodilator inhalers? A qualitative study.

Cole S, Seale C, Griffiths C.

BMJ Open. 2013 Feb 19;3(2). pii: e002247. doi: 10.1136/bmjopen-2012-002247. Print 2013.

16.

Inhaled corticosteroids in lung diseases.

Raissy HH, Kelly HW, Harkins M, Szefler SJ.

Am J Respir Crit Care Med. 2013 Apr 15;187(8):798-803. doi: 10.1164/rccm.201210-1853PP.

17.

Comparison of physician-, biomarker-, and symptom-based strategies for adjustment of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized controlled trial.

Calhoun WJ, Ameredes BT, King TS, Icitovic N, Bleecker ER, Castro M, Cherniack RM, Chinchilli VM, Craig T, Denlinger L, DiMango EA, Engle LL, Fahy JV, Grant JA, Israel E, Jarjour N, Kazani SD, Kraft M, Kunselman SJ, Lazarus SC, Lemanske RF, Lugogo N, Martin RJ, Meyers DA, Moore WC, Pascual R, Peters SP, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Wasserman SI, Walter MJ, Wechsler ME, Boushey HA; Asthma Clinical Research Network of the National Heart, Lung, and Blood Institute.

JAMA. 2012 Sep 12;308(10):987-97. doi: 10.1001/2012.jama.10893.

18.

Canadian Thoracic Society 2012 guideline update: diagnosis and management of asthma in preschoolers, children and adults.

Lougheed MD, Lemiere C, Ducharme FM, Licskai C, Dell SD, Rowe BH, Fitzgerald M, Leigh R, Watson W, Boulet LP; Canadian Thoracic Society Asthma Clinical Assembly.

Can Respir J. 2012 Mar-Apr;19(2):127-64. Erratum in: Can Respir J. 2013 May-Jun;20(3):185.

19.

Asthma outcomes: exacerbations.

Fuhlbrigge A, Peden D, Apter AJ, Boushey HA, Camargo CA Jr, Gern J, Heymann PW, Martinez FD, Mauger D, Teague WG, Blaisdell C.

J Allergy Clin Immunol. 2012 Mar;129(3 Suppl):S34-48. doi: 10.1016/j.jaci.2011.12.983. Review.

20.

As Needed Use of Inhaled Corticosteroids for Management of Mild Persistent Asthma in Children.

Raissy HH, Blake K.

Pediatr Allergy Immunol Pulmonol. 2011 Dec;24(4):231-233. No abstract available.

Supplemental Content

Support Center